ClinicalTrials.Veeva

Menu

A Pilot Study to Investigate Biomarkers in Anterior Cruciate Ligament (ACL) Patients and Healthy Controls

U

United Lincolnshire Hospitals NHS Trust

Status

Completed

Conditions

Rupture of Anterior Cruciate Ligament

Treatments

Procedure: Surgeons knowledge of pre-operative PBIs

Study type

Interventional

Funder types

Other

Identifiers

NCT02300012
120614Mullineaux

Details and patient eligibility

About

Incident rates of ACL rupture are greatest in 16-39 year olds at almost 1 in 1,000.

Performance Based Investigations (PBIs) can be used to evaluate and select correct approaches to patient treatment, and biochemical, biomechanical and physiological biomarkers in other conditions are sensitive in distinguishing between disease state severities, type of injuries and responsiveness to treatment. Despite the measurement sensitivity of PBIs, these are not widely used possibly owing to their focus postoperatively where benefits are less worthwhile.

This study aims to investigate novel biomarkers as performance based investigations (PBIs) to improve surgical and treatment strategies in anterior cruciate ligament (ACL) patients. The objectives are to identify whether biomarkers, collected before and after operations, can: 1) Assist the surgeon in decision making; 2) Lead to improved prognosis; 3) Be used to predict the outcomes of prognosis, and; 4) Correlate with disease signs/ smoking to help further understand ACL injuries.

Enrollment

8 patients

Sex

All

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • unilateral ACL rupture
  • 18 - 45 years old

Exclusion criteria

  • combined posterior and ACL rupture
  • multi-ligament instability including medial or lateral collateral ligament injury
  • other lower limb surgery <3mths
  • current significant acute injury affecting other lower extremity joints, or other relevant neurological or musculoskeletal pathology.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

8 participants in 4 patient groups

Operation - No PBI
No Intervention group
Description:
Patients requiring operation - baseline PBI data not seen by surgeon
Operation - PBI available
Experimental group
Description:
Patients requiring operation - baseline PBI data seen by surgeon pre-operatively
Treatment:
Procedure: Surgeons knowledge of pre-operative PBIs
Non-operation
No Intervention group
Description:
Patients with ACL rupture not requiring operation
Control
No Intervention group
Description:
Healthy age matched volunteers - No operation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems